PPD

Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.

Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.

Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.

Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.

Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.

Evidera provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging our unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that our clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities.

Synexus is a site network organization that continues to pioneer important developments in the clinical trials industry. Through a global network of 26 dedicated research centres (DRCs) in nine countries, Synexus provides first-class clinical trials data to its clients from pharma, biotechs and CROs. Synexus recruits patients and runs clinical trials at its own dedicated research centres staffed by full-time GCP investigators who work solely on clinical trials. It also expertise in trial planning, spanning patient recruitment, patient retention, and management. Synexus was founded in 1992 and is headquartered in Chorley, UK,

X-Chem, Inc. is a privately held biotechnology company located in Waltham, Massachusetts, founded in 2009. The company specializes in discovering small molecule leads for high-value therapeutic targets, utilizing its innovative DNA-Encoded Library (DEL) technology. This approach allows X-Chem to provide drug discovery services through the iterative combinatorial synthesis of small molecules, which are linked to DNA tags that document their synthetic history. By focusing on the generation of novel small molecule therapeutics, X-Chem aims to advance healthcare through its cutting-edge biotechnological services.

RCT Logic LLC develops and licenses clinical trial designs for use in trials sponsored by industry, non-profit entities, and governments in the United States. Its products include sequential parallel comparison design (SPCD), a clinical trial design that reduces the detrimental impact of placebo response and addresses the placebo response problem by utilizing placebo non-responders; and SPCD comparative analysis software calculator that allows a sponsor of a trial to calculate the design parameters for an SPCD trial under sponsor-provided specifications, and to analyze and understand the efficiency of SPCD in comparison to a conventional trial. The company was founded in 2007

BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing, China. Their priority is providing the highest quality, FDA-compliant services at an affordable cost. Their clients are over 40 pharmaceutical and biotechnology companies, and their services span the entire range of drug discovery and development, from discovery chemistry, through pharmacology and drug safety and evaluation, to clinical trials. Today, BioDuro is working with 10 of the 12 largest pharmaceutical companies in the world.

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutical companies. Auven Therapeutics has built a diversified portfolio of biologic and small molecule therapeutic candidates for a wide range of therapeutic indications. The Company’s existing pipeline addresses critical unmet medical needs in cancer, ophthalmic conditions, women’s health and orphan diseases. It has ownership of or a controlling interest in the therapeutic assets of ADC Therapeutics, Spirogen, Resolvyx and Kiacta, and a minority investment in Kolltan and Sprout Pharmaceuticals. Founded in 2007 by industry veterans Stephen Evans-Freke and Dr. Peter B. Corr, Auven Therapeutics Management L.L.L.P. is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda. Auven Therapeutics is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Management L.L.L.P. Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda.

Excel PharmaStudies Inc. (依格斯医疗科技有限公司) is a company focused on clinical research and contract research. It maintains close contact with government departments, industries, hospitals, and research institutes. PharmaStudies has conducted 123 clinical research projects from I to IV period in about 130 hospitals of 40 cities with the invovlment of 25,000 patients. It was founded in 1999, and is one of the earliest clinical research & contract research organizations in China.

AbCRO is a clinical research organization, provides clinical trial services to pharmaceutical and biotechnology companies in Southeastern Europe. It offers regulatory compliance, clinical monitoring, investigator recruitment, and project management services. The company was founded in 2000 and is based in Stamford, Connecticut. It was acquired in April 2009 by PPD.

Magen BioSciences is a Biotechnology company located in 100 Beaver Street, Suite 101, Waltham, MA, United States.